Drug Database
N05CD08 midazolam
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM BUCCOLAM 10 mg Oromucosal Solution
- POM BUCCOLAM 2.5mg, 5mg, 7.5mg and 10 mg oromucosal solution
- POM BUCCOLAM 5 mg Oromucosal Solution
- POM BUCCOLAM 7.5 mg Oromucosal Solution
- POM Epistatus 10 mg Oromucosal Solution
- POM Epistatus 2.5 mg oromucosal solution
- POM Epistatus 5 mg oromucosal solution
- POM Epistatus 7.5 mg oromucosal solution
- POM Hypnovel 10mg in 2ml
- POM Midazolam 1 mg/ml solution for injection/infusion
- POM Midazolam 1 mg/ml solution for injection/infusion
- POM Midazolam 1 mg/ml solution for injection/infusion in pre filled syringe
- POM Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
- POM Midazolam 10mg oromucosal solution
- POM Midazolam 1mg in 1ml Injection
- POM Midazolam 1mg/1ml Injection
- POM Midazolam 1mg/ml, solution for injection / infusion
- POM Midazolam 2 mg/ml solution for injection/infusion in pre-filled syringe
- POM Midazolam 2 mg/ml, solution for injection / infusion
- POM Midazolam 2.5mg oromucosal solution
- POM Midazolam 2mg/ml Injection
- POM Midazolam 5 mg/ml solution for injection/infusion
- POM Midazolam 5 mg/ml solution for injection/infusion
- POM Midazolam 5mg in 1ml Injection
- POM Midazolam 5mg oromucosal solution
- POM Midazolam 5mg/ml, solution for injection / infusion
- POM Midazolam 7.5mg oromucosal solution
- POM Miprosed 5mg/ml Oral Solution
- POM Ozalin
- POM OZALIN 2 mg/ml oral solution in single-dose container
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).